Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report)’s stock price passed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.35 and traded as low as $1.2864. Oxbridge Re shares last traded at $1.31, with a volume of 1,785 shares trading hands.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Oxbridge Re in a report on Wednesday, October 8th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $5.00.
Check Out Our Latest Stock Report on Oxbridge Re
Oxbridge Re Trading Down 0.8%
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last posted its earnings results on Thursday, November 6th. The insurance provider reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). Oxbridge Re had a negative return on equity of 47.76% and a negative net margin of 109.74%.The company had revenue of $0.65 million for the quarter, compared to the consensus estimate of $0.74 million.
Institutional Trading of Oxbridge Re
An institutional investor recently bought a new position in Oxbridge Re stock. Virtu Financial LLC purchased a new stake in Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 17,789 shares of the insurance provider’s stock, valued at approximately $32,000. Virtu Financial LLC owned 0.23% of Oxbridge Re at the end of the most recent quarter. Institutional investors and hedge funds own 5.64% of the company’s stock.
About Oxbridge Re
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
Featured Stories
- Five stocks we like better than Oxbridge Re
- Do not delete, read immediately
- The $100 Trillion AI Story No One Is Telling You
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- But this $2 Gold Stock Before May 20, 2026
- Wall Street Stockpicker Names #1 Stock of 2026
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
